Clinical Report: Recent Insights into E-Cigarette Utilization Among Smokers with SSD
Overview
This scoping review evaluates the use of e-cigarettes among individuals with schizophrenia spectrum disorders (SSD).
Background
Tobacco use is disproportionately high among individuals with schizophrenia spectrum disorders, leading to increased mortality from smoking-related diseases. Traditional cessation methods are less effective in this population, necessitating exploration of alternative approaches such as e-cigarettes.
Data Highlights
Three studies with a total of 323 participants were included in the review.
Key Findings
E-cigarette interventions are feasible and acceptable for individuals with SSD.
Preliminary evidence suggests e-cigarettes may lead to smoking reduction.
Decreased exposure to tobacco-related carcinogens was observed.
Clinical Implications
Healthcare providers should consider the unique challenges faced by individuals with SSD when discussing smoking cessation options. E-cigarettes may offer a viable alternative, but their use should be accompanied by behavioral support to enhance effectiveness.
Conclusion
Further research is necessary to confirm these results.
by Pasquale Caponnetto, Sarah Pratt, Carlo Maria Bellanca, Noemi Maria Vitale, Graziella Chiara Prezzavento, Giusy Rita Maria La Rosa, Yusuff Adebayo Adebisi, Ramin Nilforooshan, Isaac John, Abdulnaser Fakhrou, Antonino Petralia, Maria Salvina Signorelli, Uladzimir Pikirenia, Ines Testoni, Roberto Cavallaro, Marta Bosia, Riccardo Polosa
